🚨 In this episode of On The Pen, we break down a brand-new mouse study presented at ENDO 2025 that’s turning heads — Zepbound didn’t just help obese mice lose fat, it shrunk their breast tumors. That’s right. For the second time in a week, a GLP-1 medication is showing potential disease-fighting power beyond weight loss. We cover: • How the study was designed • What the results mean for women with obesity • Why this builds on the heart protection data we just reported This is not just about pounds lost. This is about changing the internal environment that fuels disease. Don’t miss this one. 👉 Subscribe for more GLP-1 news, explained from a patient’s perspective. 💬 Drop your thoughts in the comments — especially if this hits close to home. 📰 Read the full breakdown on Substack: [link] #Zepbound #GLP1 #ObesityMedicine #BreastCancer #ENDO2025 #OnThePen #PatientAdvocacy #Mounjaro #Tirzepatide #CancerResearch #GLP1News

All Referenced Links: https://linktr.ee/manonthemounjaro In this episode of On The Pen: Faces of the Fight, I sit down with Connecticut State Senator Matt Lesser, the lawmaker behind one of the boldest health policy moves in recent memory. We talk about Connecticut’s newly passed bipartisan prescription drug affordability bill and the groundbreaking provision buried inside it — a plan to petition the federal government for permission to manufacture their own GLP-1 medications like Ozempic. Senator Lesser explains how this little-known federal law could allow Connecticut to override pharmaceutical patents in the public interest, why the state is spending over 150 million dollars a year on GLP-1s, and how this approach could bring drug prices down not just in Connecticut, but potentially nationwide. We also dig into timelines, political strategy, and the real-world implications of a state trying to break Big Pharma’s pricing model. If you care about access, affordability, and the future of obesity treatment in America, this is one you don’t want to miss.

https://www.getclaimable.com/otp Code OTP10 Saves 10% Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro #zepbound #insurance #cvscaremark

Full article: https://substack.com/@onthepen/note/c-130749661?r=4n3ng9&utm_medium=ios&utm_source=notes-share-action Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro #alzheimer #ozempic #semaglutide

Full Study: https://www.nature.com/articles/s41591-025-03774-9 Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro #zepbound #mounjaro #foodnoise

Get obesity News to Your inbox: https://www.obesity.news Visit All Our Links: https://www.linktr.ee/manonthemounjaro #retaturtide #cagrisema #onthepen

#ADA2025 #Type2Diabetes #DietSoda Get All The News! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro

JOIN THE FIGHT HTTP://WWW.ONTHEPEN.SUBSTACK.COM

See all my links: https://linktr.ee/manonthemounjaro

CVS announces major partnership with Novo Nordisk as Lilly announces Q! 2025 earnings. Dave covers it all in today's breakdown. Join the Substack: https://substack.com/@onthepen WAYS TO SUPPORT MY WORK ⬇️ 💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS: BPC-157 // Can’t Weight // TB4-FRAG // KPV Sign up here and use code “OTP10” to save 10% https://integrativepeptides.com/OTP WHY I TRUST INTEGRATIVE PEPTIDES: 🇺🇸 Made in the USA 📋 CGMP Compliant (FDA oversight of their products) 🧑‍⚕️Trusted and Sold By Doctors and Clinics all over the USA 📕 GET MY BOOK! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp https://amzn.to/4gAXrz4 SOCIALS: 📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx 🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1 👾: https://discord.gg/ZHeUh7WV 📺: https://youtube.com/@ManOnTheMounjaro?feature=shared ❌: https://x.com/manonthepen?s=21 💻: https://www.onthepen.com https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. 🎙️ New to streaming or looking to level up? Check out StreamYard and get $10 discount! 😍 https://streamyard.com/pal/d/6163227593146368

We’ve said it for a long time. Covering GLP-1 medications isn’t just the right thing to do for your employees. It’s the smart thing. Now, we have the data to back it up. Join the Substack: https://substack.com/@onthepen WAYS TO SUPPORT MY WORK ⬇️ 💊 OVER THE COUNTER ORAL PEPTIDE SUPPLEMENTS: BPC-157 // Can’t Weight // TB4-FRAG // KPV Sign up here and use code “OTP10” to save 10% https://integrativepeptides.com/OTP WHY I TRUST INTEGRATIVE PEPTIDES: 🇺🇸 Made in the USA 📋 CGMP Compliant (FDA oversight of their products) 🧑‍⚕️Trusted and Sold By Doctors and Clinics all over the USA 📕 GET MY BOOK! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp https://amzn.to/4gAXrz4 SOCIALS: 📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx 🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1 👾: https://discord.gg/ZHeUh7WV 📺: https://youtube.com/@ManOnTheMounjaro?feature=shared ❌: https://x.com/manonthepen?s=21 💻: https://www.onthepen.com https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.

Eli Lilly has filed lawsuits against four large telehealth companies including Mochi Health, Fella and Delilah, Willow Health Services, and Henry Meds. The claim? These platforms are selling unapproved versions of tirzepatide, the same active ingredient in Mounjaro and Zepbound. In this video, we break down what Lilly is saying, why these lawsuits matter, and what this means for patients who rely on affordable access to GLP 1 medications. We also talk about Lilly’s claim that these companies are influencing prescribing decisions. From fast tracked patient evaluations to templated scripts that push compounded meds, Lilly is calling out what it says is a sales driven model that puts patient safety at risk. As the FDA shortage status ends and the legal system kicks into gear, the future of compounded GLP 1 meds hangs in the balance. If you are a patient, provider, or advocate in this space, you need to understand what is happening. #tirzepatide #lawsuit #EliLilly #compounds #mounjaro, Zepbound, GLP 1 medications, compounded tirzepatide, telehealth, Henry Meds, Mochi Health, FDA tirzepatide update, weight loss medication access, obesity treatment news

The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️ 💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS: BPC-157 // Can’t Weight // TB4-FRAG // KPV Sign up here and use code “OTP10” to save 10% https://integrativepeptides.com/OTP WHY I TRUST INTEGRATIVE PEPTIDES: 🇺🇸 Made in the USA 📋 CGMP Compliant (FDA oversight of their products) 🧑‍⚕️Trusted and Sold By Doctors and Clinics all over the USA 📕 GET MY BOOK! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp https://amzn.to/4gAXrz4 SOCIALS: 📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx 🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1 👾: https://discord.gg/ZHeUh7WV 📺: https://youtube.com/@ManOnTheMounjaro?feature=shared ❌: https://x.com/manonthepen?s=21 💻: https://www.onthepen.com #orforglipron #ozempic #mounjaro

WAYS TO SUPPORT MY WORK ⬇️ 💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS: BPC-157 // Can’t Weight // TB4-FRAG // KPV Sign up here and use code “OTP10” to save 10% https://integrativepeptides.com/OTP WHY I TRUST INTEGRATIVE PEPTIDES: 🇺🇸 Made in the USA 📋 CGMP Compliant (FDA oversight of their products) 🧑‍⚕️Trusted and Sold By Doctors and Clinics all over the USA 📕 GET MY BOOK! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp https://amzn.to/4gAXrz4 SOCIALS: 📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx 🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1 👾: https://discord.gg/ZHeUh7WV 📺: https://youtube.com/@ManOnTheMounjaro?feature=shared ❌: https://x.com/manonthepen?s=21 💻: https://www.onthepen.com #danuglipron #orforglipron #pfizer #ozempic #mounjaro #onthepen

See all my links: https://linktr.ee/manonthemounjaro

In this powerful interview, Noom CEO Geoff Cook opens up about his mission to bring down the cost of GLP-1 medications like Ozempic, Wegovy, and Zepbound—and why he believes compounding pharmacies could play a critical role in making these life-changing drugs more accessible. We dig into the failures of the U.S. healthcare system, how the Trump-era Most Favored Nation policy aimed to fight high drug prices, and why patients are still paying thousands out of pocket. If you care about affordable access to GLP-1s, compounded semaglutide, or the future of obesity care, this conversation is a must-watch.  WAYS TO SUPPORT MY WORK ⬇️ 💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS: BPC-157 // Can’t Weight // TB4-FRAG // KPV Sign up here and use code “OTP10” to save 10% https://integrativepeptides.com/OTP WHY I TRUST INTEGRATIVE PEPTIDES: 🇺🇸 Made in the USA 📋 CGMP Compliant (FDA oversight of their products) 🧑‍⚕️Trusted and Sold By Doctors and Clinics all over the USA 📕 GET MY BOOK! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp https://amzn.to/4gAXrz4 SOCIALS: 📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx 🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1 👾: https://discord.gg/ZHeUh7WV 📺: https://youtube.com/@ManOnTheMounjaro?feature=shared ❌: https://x.com/manonthepen?s=21 💻: https://www.onthepen.com #ozempic #mounjaro #onthepen

See all my links: https://linktr.ee/manonthemounjaro

See all my links: https://linktr.ee/manonthemounjaro Eli Lilly launched Mounjaro for weight loss and diabetes in India. Why is it so much more expensive than in the US?